ImmunityBio Competitors and Similar CompaniesClear all
MABION's competitors and similar companies include Sonnet BioTherapeutics and Cugene.
 MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. |  Cugene Cugene is a company dedicated to the discovery and development of medicines for treating cancer and inflammatory disorders. | |
Founding Date | Founding Date 2007 | Founding Date 2011 | Founding Date N/A |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Konstantynów Łódzki, PL HQ | Locations Princeton, US HQ | Locations Waltham, US HQ |
Employees | Employees 95 | Employees 12 | Employees 15 |
Valuation ($) | Valuation ($) 21.7 m | Valuation ($) 2.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $1m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income (zł62.6m) (FY, 2025) | Net income ($16m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Sonnet BioTherapeutics
HQ
Princeton, US
Employees
12
Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company.
View companyCugene
HQ
Waltham, US
Employees
15
Cugene is a company dedicated to the discovery and development of medicines for treating cancer and inflammatory disorders.
View company